Regeneron Ventures — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

ISA Pharmaceuticalsisa-pharma.comJul 2021

Netherlands-based developer of fully synthetic immune therapies against cancer and persistent viral infections using a synthetic long peptide platform.

Co-investorsCancer Focus Invest-NL

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.